Alerts
View all our safety alerts, medicine shortage alerts and product recalls.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Safety (5)
- (-) Shortages (2)
- Alert/Advisory (12)
- Medicine safety (8)
- Prescription medicines (5)
- Australian Register of Therapeutic Goods (ARTG) (3)
- Listed medicines (3)
- Medical devices safety (3)
- Regulatory compliance (3)
- Complementary medicines (2)
- Import and export (2)
- Advertising (1)
- Labelling and packaging (1)
- Non-prescription medicines (1)
- Over the counter (OTC) medicines (1)
- Therapeutic goods regulation (1)
- Weight loss products (1)
Search
7 result(s) found, displaying 1 to 7
-
Market actionsBliss Baby is recalling all batches of ARTG 351147 - Flatus tube, single-use - Lufti Colic Reliever, due to insufficient evidence provided to the TGA to support its safe use.
-
Medicine shortage alertsRitalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.
-
Market actionsTakeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.
-
Market actionsReynard Health Supplies is conducting a Critical Recall of the above products. A contamination problem has been identified with the products.
-
Safety alertsMore prominent warnings are being added to the Product Information and Consumer Medicine Information for all oral and injectable (systemic) fluoroquinolones to strengthen existing warnings about serious side effects.
-
Safety alertsPossible risk of learning, communication and behaviour problems in children born to men taking this medicine.
-
Safety alertsExtra safety information is being added to all montelukast products to highlight the existing warnings about serious behaviour and mood-related changes